We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimer's Disease Treated with Rivastigmine.
- Authors
Boada, Mercè; Arranz, Francisco Javier
- Abstract
Background and Aims: Poor adherence to anti-dementia drugs is common among patients with Alzheimer's disease. This study evaluated whether caregivers were more satisfied with, and patients more adherent to, transdermal rivastigmine than oral rivastigmine. Methods: Neurologists, psychiatrists and geriatricians collected sociodemographic and clinical data from 1,078 patients and administered the Treatment Satisfaction with Medicines (SATMED-Q) and the Morisky-Green questionnaires to their caregivers at outpatient consultations. Results: Satisfaction reported was greater with transdermal than oral rivastigmine: mean ± SD of the total SATMED-Q score, 72.5 ± 14.1 vs. 65.2 ± 12.5, p < 0.001. The proportion of adherent patients was greater with transdermal than with oral rivastigmine (65.0 vs. 41.4%, p < 0.001). Satisfaction, in turn, was significantly greater in adherent cases than in nonadherent cases. Conclusions: Facilitating the administration of anti-dementia drugs would improve adherence. Copyright © 2013 S. Karger AG, Basel
- Subjects
SPAIN; RESEARCH; ALZHEIMER'S disease; CAREGIVERS; CHI-squared test; COMPARATIVE studies; RIVASTIGMINE; CONFIDENCE intervals; DEGLUTITION; DRUGS; DRUG administration; EPIDEMIOLOGY; MEDICAL cooperation; ORAL drug administration; PATIENT compliance; PATIENT satisfaction; QUESTIONNAIRES; RESEARCH funding; SCALES (Weighing instruments); TRANSDERMAL medication; DATA analysis; MULTIPLE regression analysis; CROSS-sectional method; SEVERITY of illness index; DESCRIPTIVE statistics; THERAPEUTICS
- Publication
Dementia & Geriatric Cognitive Disorders, 2013, Vol 35, Issue 1/2, p23
- ISSN
1420-8008
- Publication type
Article
- DOI
10.1159/000345989